MedPath

APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

97046027IP2

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Apr 2, 2025

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number97046027IP2
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

IRBESARTANActive
Quantity: 300 mg
Name: IRBESARTAN

ATC CLASSIFICATION (3)

C09C
C09CA
C09CA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.